Palantir’s Push for GP Data Access Sparks NHS Privacy Debate
US data firm Palantir has reportedly lobbied ministers to allow its Federated Data Platform to operate on NHS GP records. The request, revealed through freedom of information disclosures and media reporting, has reignited concerns about patient privacy, consent and the governance of AI tools used in public healthcare.
Expanding AI’s Reach Beyond Current NHS Contracts
Palantir already supplies data infrastructure used by parts of the NHS. Recent lobbying asked officials to extend that platform into primary care data so AI models could access GP-held information. Lobbying actions included meetings with Department of Health officials and submissions framing the platform as compatible with existing NHS digital programmes. Proponents say federated approaches limit raw data movement, while critics worry about downstream uses and third party access.
Why GP Data Is Especially Sensitive
GP records contain longitudinal patient histories, free-text notes, mental health details and social risk factors. Unlike secondary care datasets, primary care records often include granular day-to-day clinical observations and sensitive information collected over many years. That depth raises risks of re-identification and harms if governance is weak or consent routes are unclear.
Patient Trust, Campaigners and Policy Responses
Unions, campaign groups and some clinicians have warned that extending platform access without robust safeguards could erode public trust and deter patients from sharing information. The government has promoted the idea of a UK sovereign AI ecosystem to keep critical systems under national control. How that policy aligns with outsourcing elements of infrastructure to foreign firms remains contested.
Possible Outcomes for Palantir and NHS Data Governance
Likely scenarios include stricter transparency requirements, tighter contractual limits on data use, or legal and parliamentary scrutiny. Policymakers may press for stronger audit trails, clearer patient opt-out mechanisms and independent oversight before any expansion proceeds. The episode highlights the wider debate over how AI can be introduced into health systems while protecting patient rights and maintaining public confidence.
